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Background and aims: Vibrio vulniﬁcus causes an infectious disease that has extremely poor
convalescence  and leads to necrotic fasciitis. In this study, we sought to deﬁne the charac-
teristic  epidemiology of V. vulniﬁcus infection and clarify its diagnosis at the global level.
Methods: Over a period of 10 years, we investigated the appearance of symptoms, underlying
conditions,  treatment, and mortality in 12 patients (eight men, four women; >50 years old;
average  age, 66 years,) infected with V. vulniﬁcus.
Results: The development of symptoms occurred primarily between June and September, a
period during which seawater temperature rises and the prevalence of V. vulniﬁcus increases.
All  patients had underlying diseases, and seven patients reported a history of consuming
fresh  ﬁsh and uncooked shellﬁsh. The patients developed sepsis and fever with sharp pain in
the limbs. Limb abnormalities were observed on visual examination. All patients underwent
debridement;  however, in the survival group, the involved limb was amputated early in 80%
patients.  The mortality rate was 58.3%.
Conclusion: Recognition of the characteristic epidemiology and clinical features of this dis-ease is important, and positive debridement should be performed on suspicion. When the
illness  reaches an advanced stage, however, amputation should be the immediate treatment
of  choice.
©  2013  Elsevier  Editora Ltda. Este é um artigo Open Access sob a licença de CC BY-NC-NDntroduction
ibrio vulniﬁcus is a Gram-negative bacillus identiﬁed by
armer  in 1979. It is present in coastal seawater, and induces
ymptoms of necrotizing fasciitis.1 Until recently, V. vulniﬁ-
us  infection was  restricted to brackish water regions with
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  Este é um artigo Open Access sob a licença dwarm weather and low sea salt concentration. For example,
40%  of all V. vulniﬁcus-infected individuals live in the north-
ern  region of Kyushu, which is adjacent to the Ariake Sea, a
shallow  brackish water region. However, global warming inotmail.com (Y. Matsuoka).
recent  years has increased sea temperature, and the symp-
toms  of V. vulniﬁcus infection have been observed in areas
not  endemic to this infection.2 Despite its high fatality rate,
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Fig. 1 – Classiﬁcation of underlying disease.
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Fig. 2 – Relationship between seawater temperature and
(SIRS) and sepsis, hepatic dysfunction, renal disorders,
and clotting abnormalities. Eight patients had dissemi-
nated intravascular coagulation (DIC). No patient had acute
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V. vulniﬁcus infection is rare, and knowledge about this infec-
tion  is low. By re-examining the accumulated cases at our
hospital,  we  wish to investigate the diagnosis and treatment
of  V. vulniﬁcus infection and provide information regarding this
at the global level.
Research  purpose
By investigating recently infected patients at our hospital, we
sought to clarify the clinical features and route of V. vulniﬁcus
infection. Patients were  divided into a death group and a sur-
vival  group to investigate the differences in treatment. A ﬂow
chart  from diagnosis to treatment of V. vulniﬁcus infection was
then  prepared.
Patients  and  methods
Twelve patients with V. vulniﬁcus-induced necrotic fasciitis,
who  consulted our department between January 2001 and
December  2010, were  included in this retrospective study
based  on patients’ clinical records. Patient characteristics and
route  of infection were investigated, followed by establish-
ing  a relationship between the month of symptom onset and
seawater  temperature in that month; a graph was  created
based  on the results (Study 1). Physical and laboratory ﬁnd-
ings  at the ﬁrst medical examination were analyzed (Study 2).
The patients were  divided into a survival group and a death
group  to investigate differences in treatment (Study 3). Med-
ical  treatments primarily included antibiotic administration,
debridement, and limb amputation. Differences in the time
between  calling for an ambulance and treatment initiation
were  examined. History of raw seafood consumption, which
was  reported by the family, was  ambiguous, and the time from
consuming  uncooked seafood to the development of symp-
toms  differed among patients; some patients may  have had
an  incubation period of several days. Considering that the
patients  would call an ambulance on appearance of severe
symptoms, which also indicates increased bacilli in the blood,
the  time of calling for an ambulance was  considered as dis-
ease  onset. Subsequently, the time between disease onset and
death  was  investigated.
Results
(Study  1)  Patient  characteristics  and  route  of  infection
The study included eight men  and four women (sex ratio, 2:1),
all  aged above 50 years (average age, 66 years). All patients
had  underlying diseases. Six, ﬁve, three, and one patient had
liver  dysfunction or liver cirrhosis, diabetes, cancer, and poor
nutritional  status due to mental disease, respectively. When
two  or more  underlying diseases were present in one patient,
they  were  overlapped and counted (Fig. 1). The time between
fresh  ﬁsh or shellﬁsh consumption and disease onset ranged
from  several hours to two days for seven patients; this time
was  unknown for ﬁve patients.
Next, the relationship between the month of symp-
tom onset and seawater temperature in that month waspatient  number.
investigated. Eight patients developed symptoms between
June  and September, whereas two, one, and one patient
developed symptoms in December, May, and October, respec-
tively.  The seawater temperature along the coast of the
Kyushu  district is approximately 10 ◦C from January to
March,  rising gradually by 10 ◦C in April and May  to
exceed 20 ◦C, where it remains until September before
declining gradually. The graph created on the basis of
these  data indicated that the higher incidence of symptom
development between June and September correlated with
the  increased seawater temperature during these months
(Fig.  2).
(Study  2)  Physical  and  laboratory  ﬁndings
At the ﬁrst medical examination, all patients exhibited
fever and sharp pain in the limbs, which exhibited red-
ness,  swelling, purple spots, and/or blister formation on
visual  examination. Five patients exhibited stomachache,
nausea, and vomiting. Only one patient exhibited full-
blown  necrosis (Fig. 3). As per laboratory ﬁndings, all
patients had systemic inﬂammatory response syndromevisual
examination
of limbs
vomiting
Fig. 3 – Physical ﬁndings at the ﬁrst medical examination.
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Fig. 4 – Laboratory ﬁndings at the ﬁrst medical
examination.
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Fig. 7 – Time to debridement.
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espiratory distress syndrome (ARDS) or consciousness disor-
ers  (Fig. 4).
Study  3)  Treatment  differences  between  the  survival  and
eath groups
he mortality rate of the patients was  58.3% (7/12); 71% (5/7)
atients  died within two days (Fig. 5). There was  no differ-
nce  between the two groups in the time between symptom
nset  and antibiotic initiation, and the types and doses of
ntibiotics  were  similar for both groups (Fig. 6). No patient was
reated  only with antibiotics. Although all patients underwent
ebridement, it was  performed earlier in the survival group
han  in the death group (Fig. 7). All patients in the survival
roup underwent amputation, which was  performed early in
any of these patients (Fig. 8). Two patients converted to
mputation during debridement itself. Three patients under-
ent  amputation 3 h after debridement because of circulatory
nstability and abnormal leg skin color. Using the time of the
rst  amputation as a reference, it was  calculated that the
urvival  group underwent amputation earlier than the death
roup,  and less than half death group patients were  eligi-
le  for amputation. Mortality increases if the time between
isease  onset and amputation exceeds 8 h, and it was  100% in
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Fig. 6 – Time to antibiotic initiation.Fig. 8 – Time to lower extremity amputation.
patients in whom amputation was delayed by 12 h. Regarding
debridement, mortality increases if the time exceeds 4 h, and
it  was 100% in patients in whom debridement was delayed by
8  h. The relationship between mortality and time from disease
onset  to debridement and amputation was  plotted on a graph
(Fig.  9).
Discussion
Although V. vulniﬁcus multiplies in approximately 10 min  at
20 ◦C, its multiplication is controlled below 15 ◦C.3 Moreover, it
is  believed that approximately one million bacilli are required
to  cause infection via oral ingestion.4 For V. vulniﬁcus infec-
tion  to materialize, uncooked and V. vulniﬁcus bacilli that grew
at  a seawater temperature of at least 20 ◦C must have been
consumed by the patients via raw fresh ﬁsh or shellﬁsh that
ingested  this bacilli, which in turn condensed in the digestive
organs  of these ﬁsh. Age, disease status, and immune function
inﬂuence  V. vulniﬁcus multiplication, which could explain why
all patients in this study were  >50 years old and had under-
lying  diseases such as diabetes and hepatic dysfunction.5Additionally, most patients were infected between June
and  September, during which seawater temperature is ele-
vated.  Fifty-eight percent patients (7/12) reported a history of
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Fig. 9 – Relationship between mortality rate and time to
debridement and lower extremity amputation.
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consuming fresh ﬁsh and shellﬁsh; this rate could be higher
if  the history of the remaining 42% patients (5/12) was
known. The two patients who developed symptoms in
December may  have consumed raw oysters, which report-
edly  have higher contamination rates than those of other
shellﬁsh.5,6
V. vulniﬁcus infection, although rare, typically manifests
between June and October in patients with the following char-
acteristics:  60 years old, underlying diseases such as liver
dysfunction and diabetes, consume raw ﬁsh and shellﬁsh.
Because the time of treatment initiation is important, iden-
tifying  potential cases of infection is critical. Although fever,
sharp  limb pain, and limb abnormalities were observed in
all  patients, necrosis of the extremities, a deﬁning charac-
teristic  of V. vulniﬁcus infection, was  identiﬁed only in one
patient.  Necrosis is uncommonly observed at the ﬁrst exam-
ination;  this is the primary cause of delayed diagnosis and
medical  treatment. If no limb severities are observed at initial
examination, cellulitis/phlegmon may  be suspected. Because
V.  vulniﬁcus multiplies rapidly and increases to one million
in  2 h in a blood vessel, a patient’s condition can deterio-
rate  rapidly.7 Although skin necrosis accompanied by a blood
blister  is observed after several hours, numerous bacilli will
be  present in this blister and treatment will no longer be
effective.8,9
An unexpectedly high number of abdominal symptoms
were  observed in our study. If a healthy person is infected
by  this bacillus, he/she will have only stomachache and diar-
rhea  as symptoms. Is it the same phenomenon? Liver and
renal  dysfunction may  be caused by an underlying disease, but
these conditions may  be obstacles to patient recovery. Clotting
abnormalities were  detected in all patients, and 70% exhibited
the  diagnostic criteria of DIC. Conversely, no consciousness
disorders or respiratory abnormalities were observed at the
ﬁrst  medical examination.
The  mortality rate in this study was  58.3% (7/12), in line
with  previous ﬁndings.10 Although the system of emergency
centers and intensive care units in our country has sub-
stantially improved of late, this infection remains troubling
because patients can die within two days, as in our study.
Because it takes 48 h to identify the bacillus by laboratory cul-
ture,  medical treatment started after identifying the causative
pathogen  would be ineffective.
Regarding  treatment options, there is no deﬁnitive cure,
although there is no objection to early intervention with
antibiotics and surgery.11,12 No signiﬁcant differences in the
type  of antibiotic, administered dose, or the time of ﬁrst
administration were observed in our study groups. V. vulniﬁcus
is  a Gram-negative bacillus, and because it is not a resis-
tant  bacterium, present-day broad-spectrum antibiotics are
considered  effective. However, because this bacillus rapidly
multiplies, it is unclear whether antibiotic administration is
sufﬁcient to improve the condition of immune-suppressed
patients. In fact, no patient was  treated only with antibiotics
in  our study.
The  survival group in our study underwent debridement
and amputation earlier than the death group. Although
patients in the death group were stable at the ﬁrst medi-
cal  examination, treatment was  delayed because their family
doctors  initially diagnosed them with cellulitis/phlegmon and2 0 1 3;1  7(1):7–12
designed  a corresponding treatment plan. However, after sev-
eral hours, their general state and skin condition deteriorated,
and  debridement was performed confusedly. Four patients
died  without surgery because of unstable general health.
Debridement at an early stage and, if medical treatment is
resisted,  enforcing amputation of the lower extremities should
be  performed immediately to increase chances of patient sur-
vival.  According to our data, debridement and amputation
should be performed within 4 h and 8 h, respectively. Mortal-
ity  will increase if this window is missed because V. vulniﬁcus
multiplies rapidly; therefore, it will be impossible to eliminate
the  bacillus after this time.13,14 To permit timely surgical man-
agement, early suspicion and diagnosis of this fatal infection
is  important.
A ﬂow chart from diagnosis to treatment was  created from
the  data obtained in this study (Table 1). Diagnosis of V. vulniﬁ-
cus  is ﬁrst based on suspicion. As noted previously, V. vulniﬁcus
infection  is commonly misdiagnosed as cellulitis/phlegmon
because of the lack of standardized diagnostic criteria. Com-
bining  clinical history with a medical examination is helpful
in  predicting V. vulniﬁcus infection. Various cultures, partic-
ularly  in thiosulphate-citrate-bile salts-sucrose (TCBS) agar
medium,  and blood and ﬂuid contents of blood blisters15
should be submitted while beginning preparations or standby
for  an urgent surgery. If V. vulniﬁcus is detected in a TCBS
agar  medium culture, diagnosis is quick and accurate.16 If a
Gram-negative banana-shaped organism is detected by Gram
staining,  the possibility of V. vulniﬁcus infection is very high.
Antibiotics should be initiated after submitting cultures. Any
antibiotic  that is effective against Gram-negative bacilli is
expected  to be effective against V. vulniﬁcus. X-rays of the
affected  limb are necessary to rule out gas gangrene. Blood
tests  will determine clotting abnormalities, liver or renal dis-
orders,  and DIC depending on the case. If blister formation is
observed  on the skin, debridement should be initiated under
general  anesthesia. Although abnormalities such as low blood
pressure  and bleeding tendencies are related to poor progno-
sis,  debridement should be performed within 4 h to maximize
patient  survival. Furthermore, depending on intraprocedural
observations, amputation of the lower extremities should be
performed without delay. The patient’s general condition usu-
ally stabilizes after removal of the affected tissue. If this does
not  happen, further amputation of the lower extremity (ream-
putation)  should proceed promptly within 8 h. If detection and
treatment  are not performed early in the course of infection,
the  mortality rate is very high. The presence of underlying
diseases such as liver dysfunction and diabetes and the pres-
ence  of symptoms such as warmth, sharp limb pain, and skin
abnormalities are characteristic features and aid in diagno-
sis.  If diagnosis and treatment are delayed, the effectiveness
of  antibiotics, debridement, and amputation decreases. It is
very important for a clinician to recognize the characteristic
epidemiology and clinical picture identiﬁed in this research
and  to perform quick diagnosis and treatment according to
the  ﬂow chart presented in this paper.
Because V. vulniﬁcus infection is very rare and followspatients  even before diagnosis. This report clariﬁes the diag-
nostic  criteria for V. vulniﬁcus infection, thereby aiding in early
diagnosis  worldwide. The strategy of this article will be helpful
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Table 1 – Flow chart from diagnosis to treatment of Vibrio vulniﬁcus.
Strategy
When a patient in his 60s presents with sharp pain in his/her leg, the following clinical history should be examined:
Is he/she at least 60 years old?
Does  he/she have hepatic dysfunction and diabetes as underlying conditions?
Did his/her symptoms ﬁrst appear between June and October?
Does he/she have a history of consuming raw food?
Next, a medical examination should be performed.
Does he/she have fever?
Does  he/she have sharp limb pain?
Are certain abnormalities observed on his/her skin?
Does he/she have stomachache, nausea, or vomiting?
Does he/she have systemic inﬂammatory response syndrome?
When these conditions are conﬁrmed, V. vulniﬁcus infection is strongly suspected.
Medical treatment is initiated according to the following ﬂow chart.
1:
Urgent surgery is planned while maintaining a dynamic circulatory state.
Usually, consciousness is maintained, and the respiratory state is satisfactory in many cases.
We should consider focusing on stabilizing circulation ﬁrst.
General anesthesia is quickly induced.
2:
Blood  and the liquid contents of blood blisters are submitted for culture.
The detection of a banana-shaped Gram-negative bacillus by Gram’s staining is indicative of V. vulniﬁcus.
As laboratory culture will require 2 days, medical treatment should be initiated before the result is obtained.
TCBS agar medium cultures should also be prepared.
3:
Sufﬁcient antibiotic doses are prescribed for the patient as soon as possible.
Any antibiotic that is effective against Gram-negative bacilli can be used.
Although it is not a resistant bacterium, the speed of multiplication of this bacterium is extremely rapid.
4:
When performing chest X-rays required for general anesthesia, an X-ray of the affected limb should also be performed to rule out gas
gangrene.
Check for gas patterns in subcutaneous tissue.
5:
Clotting abnormalities, hepatic dysfunction, and renal disorders are judged on the basis of the inspection data.
Many patients will meet the criteria for a DIC diagnosis.
6:
First, debridement is performed under general anesthesia.
Although abnormalities such as low blood pressure and bleeding tendencies indicate a poor prognosis, debridement should be performed
within 4 h to maximize patient survival.
To stabilize the patient’s general condition, do not admit the patients to ICU; the general condition will not improve unless the bacillus is
eliminated.
Depending on intraprocedural ﬁndings, leg amputation should be performed without hesitation.
The patient’s general condition should be stabilized after treatment.
7:
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rWhen the general state is not stabilized by debridement and am
In this case, re-amputation should be performed within 8 h.
o inexperienced physicians or surgeons who do not specialize
n  infectious diseases.
onclusion
he mortality rate for V. vulniﬁcus infection remains high.
However,  infected patients have typical characteristics.
atient survival is increased if the infection is diagnosed, or
t  least suspected, at the ﬁrst medical examination.
The effectiveness of debridement and lower extremity
mputation decreases over time.
The characteristic epidemiology and clinical picture pre-
ented  in this paper should be recognized, and the possibility
f  saving patient’s lives should be maximized by performingion, it is likely that multiplication of the bacillus has not ceased.
early  diagnosis and treatment according to the ﬂow chart pre-
sented  in this paper.
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